The case for vaccinating boys against human papillomavirus

Public Health Genomics

Volumn 12, Issue 5-6, 2009, Pages 362-367

  Hull, Sarah C ^a   Caplan, Arthur L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cervarix; Gardasil; Herd immunity; Vaccination ethics; Vaccination policy

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; BOY; COST EFFECTIVENESS ANALYSIS; DRUG APPROVAL; DRUG COST; DRUG SAFETY; GENDER BIAS; HERD IMMUNITY; HUMAN; INFECTION RISK; POLICY; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RISK BENEFIT ANALYSIS; SUMMER; VACCINATION; VIRUS INFECTION; WART VIRUS; WOMEN'S HEALTH;

ADOLESCENT; CHILD; DEVELOPING COUNTRIES; ETHICS, MEDICAL; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; MALE; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; PUBLIC POLICY; SEX FACTORS; WORLD HEALTH;

HUMAN PAPILLOMAVIRUS;

EID: 69249159946     PISSN: 16624246     EISSN: None     Source Type: Journal    
DOI: 10.1159/000214926     Document Type: Article

References (36)

1. Cohen J: Public health: high hopes and dilemmas for a cervical cancer vaccine. Science 2005; 308: 618-621.
2. Reichman R: Epidemiology of human papillomavirus infections. UpToDate 2007.
3. Chan JK, Berek JS: Impact of the human papilloma vaccine on cervical cancer. J Clin Oncol 2007; 25: 2975-2982.
4. Insinga RP, Dasbach EJ, Elbasha EH: Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature. Pharmacoeconomics 2005; 23: 1107-1122.
5. Parkin DM: The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118: 3030-3044.
6. Fremont AM, Correa-de-Araujo R, Hayes SN: Gender disparities in managed care: it's time for action. Womens Health Issues 2007; 17: 116-119.
7. Kahn JA, Slap GB, Bernstein DI, Tissot AM, Kollar LM, Hillard PA, Rosenthal SL: Personal meaning of human papillomavirus and Pap test results in adolescent and young adult women. Health Psychol 2007; 26: 192-200.
8. Wassenaar TR, Eickhoff JC, Jarzemsky DR, Smith SS, Larson ML, Schiller JH: Differences in primary care clinicians' approach to non-small cell lung cancer patients compared with breast cancer. J Thorac Oncol 2007; 2: 722-728.
9. McCaffery K, Forrest S, Waller J, Desai M, Szarewski A, Wardle J: Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK. Br J Cancer 2003; 88: 42-46.
10. Ohaeri JU, Campbell OB, Ilesanmil AO, Ohaeri BM: Psychosocial concerns of Nigerian women with breast and cervical cancer. Psychooncology 1998; 7: 494-501.
11. Perrin KK, Daley EM, Naoom SF, Packing-Ebuen JL, Rayko HL, McFarlane M, McDermott RJ: Women's reactions to HPV diagnosis: insights from in-depth interviews. Women Health 2006; 43: 93-110.
12. Friedman AL, Shepeard H: Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. Health Educ Behav 2007; 34: 471-485.
13. De Melo-Martin I: The promise of the human papillomavirus vaccine does not confer immunity against ethical reflection. Oncologist 2006; 11: 393-396.
14. Waller J, Marlow LA, Wardle J: The association between knowledge of HPV and feelings of stigma, shame and anxiety. Sex Transm Infect 2007; 83: 155-159.
15. Monk BJ, Wiley DJ: Will widespread human papillomavirus prophylactic vaccination change sexual practices of adolescent and young adult women in America? Obstet Gynecol 2006; 108: 420-424.
16. Klitzman R, Bayer R: Truth and Lies in the Age of AIDS. Baltimore, Johns Hopkins University Press, 2003.
17. Freeman S: Criminal liability and duty to aid the distressed. Univ Penn Law Review 1994; 142 :2001-2040.
18. Beauchamp T, Childress J: Principles of Biomedical Ethics, ed 5. Oxford, Oxford University Press, 2008.
19. Igneski V: Perfect and imperfect duties to aid. Social Theory Pract 2006;32: 439-466.
20. Malek RS, Goellner JR, Smith TF, Espy MJ, Cupp MR: Human papillomavirus infection and intraepithelial, in situ, and invasive carcinoma of penis. Urology 1993; 42: 159-170.
21. Ault KA: Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a review. Obstet Gynecol Surv 2006; 61:S26-S31.
22. François G, Duclos P, Margolis H, Lavanchy D, Siegrist CA, Meheus A, Lambert PH, Emiroǧlu N, Badur S, Van Damme P: Vaccine safety controversies and the future of vaccination programs. Pediatr Infect Dis J 2005; 24: 953-961.
23. Eickhoff TC, Myers M: Workshop summary: aluminum in vaccines. Vaccine 2002; 20:S1-S4.
24. Harper DM: Human papillomavirus vaccines. UpToDate 2007.
25. Souayah N, Nasar A, Suri MF, Qureshi AI: Guillain-Barré syndrome after vaccination in United States: a report from the CDC/ FDA Vaccine Adverse Event Reporting System. Vaccine 2007; 25: 5253-5255.
26. Schattner A: Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 2005; 23: 3876-3886.
27. Hull SC, Caplan AL: Genital warts: mountains or molehills? Lancet Infect Dis 2008; 8: 277-278.
28. Giuliano A, Palefsky J, on behalf of the Male Quadrivalent HPV Vaccine Efficacy Trial Study Group: The efficacy of quadrivalent HPV (types 6/11/16/18) vaccine in reducing the incidence of HPV-related genital disease in young men. EUROGIN Congress, Nice, 2008.
29. Dempsey AF, Koutsky LA: National burden of genital warts: a first step in defining the problem. Sex Transm Dis 2008; 35: 361-362.
30. Dinh TH, Sternberg M, Dunne EF, Markowitz LE: Genital warts among 18- to 59-year-olds in the United States, National Health and Nutrition Examination Survey, 1999-2004. Sex Transm Dis 2008; 35: 357-360.
31. Woodhall S, Ramsey T, Cai C, Crouch S, Jit M, Birks Y, Edmunds J, Newton R, Lacey CJ: Estimation of the impact of genital warts on health-related quality of life. Sex Transm Infect 2008; 84: 161-166.
32. Ireland JA, Reid M, Powell R, Petrie KJ: The role of illness perceptions: psychological distress and treatment-seeking delay in patients with genital warts. Int J STD AIDS 2005; 16: 667-670.
33. Derkay CS, Darrow DH: Recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2006; 115: 1-11.
34. Freed GL, Derkay CS: Prevention of recurrent respiratory papillomatosis: Role of HPV vaccination. Int J Pediatr Otorhinolaryngol 2006; 70: 1799-1803.
35. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML: Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26: 612-619.
36. Fine P, Mulholland K: Community immunity; in Plotkin S, Orenstein W, Offit P (eds): Vaccines, ed 5. Amsterdam, Elsevier Saunders, 2008, pp 1573-1592.